UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000044302
Receipt No. R000042857
Scientific Title Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery
Date of disclosure of the study information 2021/05/24
Last modified on 2022/05/02 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery
Acronym Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery
Scientific Title Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery
Scientific Title:Acronym Comparison of Continuous Thoracic Epidural and Paravertebral Blocks for postoperative Analgesia and Complications after Minimally Invasive Cardiac Surgery
Region
Japan

Condition
Condition mitral regulation
Classification by specialty
Anesthesiology Cardiovascular surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To compare continuous thoracic epidural analgesia and paravertebral block for postoperative analgesia in patients undergoing minimally invasive cardiac surgery for quality of analgesia, complications.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase

Assessment
Primary outcomes The means of postoperative NRS at 0 hours (endotracheal extubation), 2hours and 6hours.
Key secondary outcomes NRS at 12hours, 24hours,48hours after extubation.
NRS at the first time after discharged hospital
Hemodynamics during operation
Postoperative course: intubation time, ICU stay, hospital stay
postoperative complications: re-intubation, Non-invasive positive pressure ventilation, pulmonary complication, arrhythmia(including new onset of atrial fibrillation or flutter), postoperative nausea and vomitting
Patient satisfaction
Side effects of epidural or paravertebral catheter insertion

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification NO
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Medicine Maneuver
Interventions/Control_1 epidural block group:

epidural block catheter insertion the day before operation.5ml administration of 0.25% revobupivacane between anesthetic induction and operation starts.
3ml per hour continuous infusion of 0.2% revobupivacaine when cardio-pulmonary bypass starts.
The catheter is removed 48hours after extubation.
Interventions/Control_2 paravertebral block group:

paravertebral block catheter insertion the day before operation.10ml administration of 0.25% revobupivacane between anesthetic induction and operation starts.
6ml per hour continuous infusion of 0.2% revobupivacaine when cardio-pulmonary bypass starts.
The catheter is removed 48hours after extubation.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adults elective cardiac surgical patients undergoing minimally invasive cardiac surgery with lateral thoracotomy under cardiopulmonary bypass
Key exclusion criteria under 18 years
re-operation
hepatic disorder
renal disorder
low platelet
coagulation disorder
intake of anticoagulant or antiplatelet drugs
chest deformity
mental illness
malignant disease
regular use of analgesics
use of steroids
collagesn disease
history of heparin-indused thrombocytopenia
allergic to heparin
allergic to local anesthetic
local infection at puncture site
disagree to this study
other reasons considered by surgeons or anesthesiologist






Target sample size 100

Research contact person
Name of lead principal investigator
1st name Chiho
Middle name
Last name Shimizu
Organization Osaka Police Hospital
Division name Anesthesiology
Zip code 5430035
Address Kitayama-cho 10-31, Tennoji, Osaka
TEL 0667716051
Email chichihoho1008@gmail.com

Public contact
Name of contact person
1st name Chiho
Middle name
Last name Shimizu
Organization Osaka Police Hospital
Division name Anesthesiology
Zip code 5430035
Address Kitayama-cho 10-31, Tennoji, Osaka
TEL 0667715051
Homepage URL
Email chichihoho1008@gmail.com

Sponsor
Institute Osaka Police Hospital
Institute
Department

Funding Source
Organization Osaka police hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Osaka Police Hospital
Address Kitayama-cho 10-31, Tennoji, Osaka
Tel 5430035
Email chichihoho1008@gmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 05 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 03 Month 12 Day
Date of IRB
2019 Year 03 Month 12 Day
Anticipated trial start date
2019 Year 08 Month 09 Day
Last follow-up date
2022 Year 04 Month 30 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2021 Year 05 Month 24 Day
Last modified on
2022 Year 05 Month 02 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042857